Abiopharma

🔍 Perpich David S. (Executive)

Company: NEW YORK TIMES CO (NYT.A)

Report Date: 2026-05-11

Detailed Transactions and Holdings:

• Sold 9,000 shares of Class A Common Stock at $77.06 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: false | shares_owned_after: 28,469.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 500 shares of Class A Common Stock (Direct)
  Date: 2026-05-11 | Code: G | equity_swap_involved: false | shares_owned_after: 27,969.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: By trust. | shares_owned_after: 1,400,000.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: By trust. | shares_owned_after: 11,000.00 | Footnotes: F3
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: As UTMA custodian for minor child. | shares_owned_after: 491.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-11 | Code: H | nature_of_ownership: As UTMA custodian for minor child. | shares_owned_after: 492.00

Footnotes:

• F1: All shares were sold at the same price.
• F2: On May 11, 2026, the reporting person donated 500 shares of directly owned Class A Common Stock to a donor-advised fund, which will use the gifted shares for charitable purposes.
• F3: The reporting person disclaims beneficial ownership of these shares.